Clinical significance of TRIM29 expression in patients with gastric cancer.

Farhadi, Javad; Mehrzad, Jamshid; Mehrad-Majd, Hassan; Motavalizadehkakhky, Alireza

Farhadi, Javad; Mehrzad, Jamshid; Mehrad-Majd, Hassan; Motavalizadehkakhky, Alireza.

Afiliação

Farhadi J; Department of Biochemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran.
Mehrzad J; Department of Biochemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran.
Mehrad-Majd H; Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Motavalizadehkakhky A; Department of Chemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran.

Gastroenterol Hepatol Bed Bench ; 15(2): 131-138, 2022.

Article em En | MEDLINE | ID: mdl-35845310

Palavras-chave

Bcl-2; Cyclin D; Gastric Cancer; Prognosis; Survival; TRIM29; Β-Catenin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gastroenterol Hepatol Bed Bench Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Irã

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google